Synlett 1994; 1994(5): 305-318
DOI: 10.1055/s-1994-22839
account
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Isosaccharino- and Glucosaccharino-Lactones as Chirons for the Syntheses of Natural Compounds and Analogs of Biological Relevance

Claude Monneret* , Jean-Claude Florent
  • *Service de Chimie, CNRS, URA 1387, Institut Curie, Section de Biologie, 26 rue d'Ulm, 75231 Paris Cedex 05, France
Further Information

Publication History

Publication Date:
22 March 2002 (online)

α-D-lsosaccharino- and α-glucosaccharino-1,4-lactones, readily obtained by alkaline treatment of abundant sugars, represent versatile chiral non-racemic starting materials for the syntheses of molecules containing a tertiary alcohol function. Their usefulness is undoubtedly illustrated by the numerous regio- and stereocontrolled syntheses of biologically relevant molecules such as antibiotics, anticancer agents, pheromones and nucleosides. 1. Introduction 1.1. Access from natural sugars 1.2. Mechanism of Formation and Synthesis 2. α-D-Isosaccharino- 1,4-lactone as starting material for 2.1. Subunits of antibiotics or antibiotic synthesis 2.2. Frontalin pheromone synthesis 2.3. Ring A of the anthracyclinone incorporation 2.4.C-branched-chain nucleoside analogs 2.5. Miscellaneous 3. α-D-Glucosaccharino- 1,4-lactone as starting material for: 3.1. Synthesis of antibiotic subunits 3.2. Total synthesis of AK-toxin II 3.3. Incorporation of anthracyclinones in ring A 3.4. C-branched-chain nucleoside analogs

    >